Skip to main content

Table 1 Outcomes at 26 weeks in adult aHUS patients receiving Ecu

From: Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date

Complete TMA response, n (%) patients

30 (73); 95% CI 57 to 86

Platelet count normalisation, n (%) patients

40 (98); 95% CI 87 to 10C

Mean (SD) platelet count increase from baseline, ×109/l

135 (114); P < 0.0001

Mean (SD) eGFR increase from baseline ml/minute/1.73 m2

29.3 (23.6); P < 0.0001

Back to article page

Critical Care

ISSN: 1364-8535